Dual inhibition of EGFR and VEGFR pathways in combination with irradiation: antitumour supra-additive effects on human head and neck cancer xenografts

Por Bozec, A, Formento, P, Lassalle, S, Lippens, C, Hofman, P, Milano, G
Publicado em 2007

Enhanced tumour antiangiogenic effects when combining gefitinib with the antivascular agent ZD6126

Por Bozec, A, Lassalle, S, Gugenheim, J, Fischel, J-L, Formento, P, Hofman, P, Milano, G
Publicado em 2006

Reply: Did animal offer relevant model for bevacizumab testing?

Por Bozec, A, Sudaka, A, Fischel, J L, Brunstein, M C, Grimaldi, M C, Milano, G
Publicado em 2008

Combined effects of bevacizumab with erlotinib and irradiation: a preclinical study on a head and neck cancer orthotopic model

Por Bozec, A, Sudaka, A, Fischel, J-L, Brunstein, M-C, Etienne-Grimaldi, M-C, Milano, G
Publicado em 2008

Fra-2/AP-1 controls adipocyte differentiation and survival by regulating PPARγ and hypoxia

Por Luther, J, Ubieta, K, Hannemann, N, Jimenez, M, Garcia, M, Zech, C, Schett, G, Wagner, E F, Bozec, A
Publicado em 2014